[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2052539T3 - Procedimiento para preparar isoxazolidinas 2,3-disustituidas. - Google Patents

Procedimiento para preparar isoxazolidinas 2,3-disustituidas.

Info

Publication number
ES2052539T3
ES2052539T3 ES87118530T ES87118530T ES2052539T3 ES 2052539 T3 ES2052539 T3 ES 2052539T3 ES 87118530 T ES87118530 T ES 87118530T ES 87118530 T ES87118530 T ES 87118530T ES 2052539 T3 ES2052539 T3 ES 2052539T3
Authority
ES
Spain
Prior art keywords
link
disstituted
isoxazolidines
prepare
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87118530T
Other languages
English (en)
Inventor
Stephan Dr Henke
Dietrich Dr Brocks
Volkmar Dr Gunzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2052539T3 publication Critical patent/ES2052539T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) EN LA QUE A REPRESENTA UN RESTO, OPCIONALMENTE SUSTITUIDO, DE LA SERIE ALQUILO, ACILO, CICLOALQUILO, ARILO Y HETEROARILO; B REPRESENTA CO, CS, C=NH, CN-ALQUILO, CN-O-ALQUILO, SO, CH2 OPCIONALMENTE SUSTITUIDO, O UN ENLACE; D REPRESENTA NH, NCH3, O, CH2, O UN ENLACE; E REPRESENTA CHOH, CO, SO O C=NH OPCIONALMENTE N-SUSTITUIDO; F REPRESENTA O, NH, NCH3, O UN ENLACE; R4 REPRESENTA UN RESTO, OPCIONALMENTE SUSTITUIDO, DE LA SERIE ALQUILO, CICLOALQUILO, ARILO Y HETEROARILO; Y R8 REPRESENTA HIDROGENO O ALQUILO OPCIONALMENTE SUSTITUIDO. SE REFIERE TAMBIEN A PROCEDIMIENTOS PARA SU OBTENCION Y A SU APLICACION COMO INHIBIDORES DE LA PROLILHIDROXILASA.
ES87118530T 1986-12-17 1987-12-15 Procedimiento para preparar isoxazolidinas 2,3-disustituidas. Expired - Lifetime ES2052539T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863643012 DE3643012A1 (de) 1986-12-17 1986-12-17 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2052539T3 true ES2052539T3 (es) 1994-07-16

Family

ID=6316346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87118530T Expired - Lifetime ES2052539T3 (es) 1986-12-17 1987-12-15 Procedimiento para preparar isoxazolidinas 2,3-disustituidas.

Country Status (21)

Country Link
US (2) US5422342A (es)
EP (1) EP0271865B1 (es)
JP (1) JP2703912B2 (es)
KR (1) KR960010349B1 (es)
AR (1) AR246528A1 (es)
AT (1) ATE81344T1 (es)
AU (1) AU599177B2 (es)
CA (1) CA1338484C (es)
DE (2) DE3643012A1 (es)
DK (1) DK171894B1 (es)
ES (1) ES2052539T3 (es)
FI (1) FI88303C (es)
GR (1) GR3006699T3 (es)
HU (1) HU201961B (es)
IE (1) IE61034B1 (es)
IL (1) IL84841A (es)
NO (1) NO175058B (es)
NZ (1) NZ222921A (es)
PH (1) PH24746A (es)
PT (1) PT86380B (es)
ZA (1) ZA879400B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
DD284030A5 (de) 1988-11-24 1990-10-31 Hoechst Ag,De Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung
DE3842197A1 (de) * 1988-12-15 1990-06-21 Hoechst Ag Rasch spaltbares substrat fuer die hiv-protease
DE4016596A1 (de) * 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DK0796855T3 (da) 1996-03-20 2002-05-27 Hoechst Ag Hæmmere af knogleresorption og vitronectin-receptorantagonister
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP1420786A2 (en) * 2001-08-23 2004-05-26 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Methods of inhibiting formation of vascular channels and proliferation using pyridinone derivatives
US7842815B2 (en) 2004-06-17 2010-11-30 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CA2570780C (en) * 2004-06-17 2013-12-03 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid
US4269772A (en) * 1980-01-14 1981-05-26 Merck & Co., Inc. Synthesis of thienamycin via trans-3-carboxymethylene-4-carboxy-5-methyl-Δ2 -isoxazoline
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
US4562187A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (Isoxazol-3-yl)arylmethanones, compositions and pharmaceutical use
DE3643957A1 (de) * 1986-12-22 1988-06-30 Bayer Ag Substituierte n-methylisoxazolidine

Also Published As

Publication number Publication date
NO875263D0 (no) 1987-12-16
GR3006699T3 (es) 1993-06-30
EP0271865B1 (de) 1992-10-07
IL84841A0 (en) 1988-06-30
DE3643012A1 (de) 1988-06-30
HU201961B (en) 1991-01-28
EP0271865A2 (de) 1988-06-22
FI88303C (fi) 1993-04-26
NO175058C (es) 1994-08-24
NZ222921A (en) 1989-08-29
AU8258987A (en) 1988-06-23
DE3782149D1 (es) 1992-11-12
IE61034B1 (en) 1994-09-07
IL84841A (en) 1992-07-15
US5422342A (en) 1995-06-06
PT86380B (pt) 1990-11-20
DK662087A (da) 1988-06-18
FI875503A0 (fi) 1987-12-15
KR960010349B1 (ko) 1996-07-30
DK171894B1 (da) 1997-08-04
HUT47956A (en) 1989-04-28
ATE81344T1 (de) 1992-10-15
IE873418L (en) 1988-06-17
JPS63165374A (ja) 1988-07-08
FI875503A (fi) 1988-06-18
AR246528A1 (es) 1994-08-31
PH24746A (en) 1990-10-01
DK662087D0 (da) 1987-12-16
NO175058B (no) 1994-05-16
JP2703912B2 (ja) 1998-01-26
PT86380A (de) 1988-01-01
AU599177B2 (en) 1990-07-12
CA1338484C (en) 1996-07-23
EP0271865A3 (en) 1990-02-07
FI88303B (fi) 1993-01-15
ZA879400B (en) 1988-07-27
KR880007497A (ko) 1988-08-27
US5610146A (en) 1997-03-11
NO875263L (no) 1988-06-20

Similar Documents

Publication Publication Date Title
ES2052539T3 (es) Procedimiento para preparar isoxazolidinas 2,3-disustituidas.
FR2403337A1 (fr) N-(heterocyclique aminocarbonyl)aryl sulfonamides herbicides, compositions les contenant et procedes les utilisant
BR8600428A (pt) Compostos heterociclicos,processo para sua preparacao,composicoes inseticidas,processo para combate a insetos daninhos,utilizacao e processo para a preparacao de composicoes
ES2173683T3 (es) Inhibidor del radical superoxido.
ES2064517T3 (es) Compuestos de piridinosulfonamida sustituida, composicion herbicida que los contiene y metodo para la preparacion de estos compuestos.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2058089T3 (es) Un procedimiento para la preparacion de un nuevo derivado de prolinal.
FI931708A (fi) Herbicida substituerade aryl-haloalkylpyrazoler
BG28556A3 (bg) Фунгицидно средство
NO840048L (no) Disubstituerte prolinderivater, fremgangsmaate til deres fremstilling og deres anvendelse
ES2118711T3 (es) Sulfonilaminocarboniltriazolinonas con substituyentes enlazados.
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES2163239T3 (es) Nuevos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9207603A (es) Deribados de acidos isoxazolcarboxilicos y procedimiento para su obtencion.
DE3681109D1 (de) Stickstoffhaltige heterozyklische verbindungen.
SE7611137L (sv) 1-bensazolylalkyl-4-substituerade piperidiner
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2052560T3 (es) Compuestos difluorcetonicos.
EA200300458A1 (ru) Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
ES2036238T3 (es) Derivados de hidroxietil-azolilo.
DK377687A (da) Triazol-fungicidpraeparater
DK628487D0 (da) Kemiske forbindelser
BR8600337A (pt) Composto de 5-carboxilado de imidazol,processo para sua preparacao,composicao fungicida e processo para combater fungos
DE3769284D1 (de) Fungizide cyclohexylamine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271865

Country of ref document: ES